Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease

ConclusionsThese simulated complication rates might help inform the degree to which complications might be reduced by targeting particular HbA1c reductions in Type 2 diabetes.This article is protected by copyright. All rights reserved.

Source: Diabetic Medicine - October 23, 2017 Category: Endocrinology Authors: S. A. Mostafa, R. L. Coleman, O. F. Agbaje, A. M. Gray, R. R. Holman, M. A. Bethel Tags: Research Article Source Type: research